Clinical Trial

Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance

Name: Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance — clinical trial record (NCT07132567)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this surveillance is to assess the safety and efficacy of Poteligeo Inj. 20 mg (mogamulizumab) in routine clinical settings.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-08-17; most recent amendment 2025-09-19.

Trial Details

NCT Number	NCT07132567
Lead Sponsor	Kyowa Kirin Co., Ltd.
Conditions	Mycosis Fungoides, Sezary Syndrome
Enrollment	15 participants
Start Date	2025-05-02
Primary Completion	2028-09 (estimated)
Study Completion	2028-11 (estimated)
Updated on ClinicalTrials.gov	2025-09-22